Prevalence of Smoking After Lung Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1099 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-01

Study Completion Date

2024-12-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Smoking is one of the main risk factors for chronic obstructive pulmonary disease (COPD), the primary indication for lung transplantation (LT) in France. Resumption of smoking after transplantation is associated with an increased risk of graft dysfunction, neoplasia and reduced survival. The prevalence of resumption of smoking after transplantation is based on few data available in the literature and is estimated at between 0 and 15%. The aim of this study is to determine the prevalence of smoking in transplantation. These results will enable healthcare professionalś to carry out information, education, prevention and support actions to help patients stop smoking throughout the transplantation process.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Smoking Prevalence at a University Hospital

NCT03268980

Tobacco Smoking

COMPLETED

Tabacco Cessation in Hospital Services

NCT07031024

Tobacco Use Cessation

RECRUITING

Benefit of Systematic Proposition of Nicotine Substitution for Patients Undergoing Surgery

NCT04572646

Smoking Cessation

TERMINATED NA

Study of Psychopathological Characteristics of Patient Smoking in Thoracic Oncology

NCT01955057

Smoking Cessation and Lung Cancer

COMPLETED

Preference-based Tools for Smoking Cessation Among Disadvantaged Smokers, a Pragmatic Randomised Controlled Trial

NCT04654585

Smoking Smoking Cessation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Smoking Lung Transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMOKING

Patients who agree to take part in the study will complete a questionnaire covering the pre- and post-transplant aspects of smoking on their lifestyle

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient who has undergone a lung transplant (single, double or heart-lung) and is being followed up in a transplant centre in France;
* Age ≥ 18 years;
* French-speaking patient;
* Patient able to give his non-opposition.

Exclusion Criteria

* Patient under guardianship or curatorship;
* Patient deprived of liberty ;
* Patient under court protection;
* Patients who object to the use of their data for this research.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No